Risk factors for Hickman-Broviac catheter complications: An experience from a Tunisian hospital
Keywords:Hickman-Broviac catheter, Complications, Risk factors, Pediatrics, Neonates
Background: Hickman-Broviac catheters have improved the care of young children needing frequent and prolonged venous access, but at the same times it has substantial morbidity, particularly in a resource-constrained setup. Our study aims to describe the experience of a Tunisian hospital and investigate the main risk factors for complications.
Methods: In this study, we included all the neonates and infants who underwent Broviac catheter insertion in the pediatric surgery department. The patients were divided into 2 groups according to the presence of complications. We compared these two groups and univariate logistic regression analyses were used to determine the risk factors for complications.
Results: Forty-three children were included in the study. The incidence of complicated catheters was 60.4%. The following factors were significantly associated with an increased risk of complications: age 6 months [OR 3.5, 95% CI: 0.6-19.3], weight 6 kg [OR 1.54, 95% CI: 0.46-5.2], emergency circumstances [OR 1.62, 95% CI: 0.8-5.4], and antibiotic-therapy as an indication for Broviac catheter insertion [OR 1.8, 95% CI: 0.5-6.2].
Conclusion: Complications seem to be more frequent in patients younger than 6 months and those with a weight of less than 6Kg. To reduce the morbidity related to the catheters, the indications should be carefully chosen.
Thomas JH, MacArthur RI, Pierce GE, Hermreck AS. Hickman-Broviac catheters: Indications and results. Am J Surg. 1980; 140:791-6.
Pessa ME, Howard RJ. Complications of Hickman-Broviac catheters. Surg Gynecol Obstet. 1985; 161:257-60.
Perdikaris P, Petsios K, Vasilatou-Kosmidis H, Matziou V. Complications of Hickman-Broviac catheters in children with malignancies. Pediatr Hematol Oncol. 2008; 25:375-84.
Jarraya A, Triki Z, Guermazi J, Abdelkafi W, Galinski M, Karoui A. Femoral venous catheterization: a case of late femoral hematoma. Pan Afr Med J. 2014; 17:206.
Zhang JJ, Nataraja RM, Lynch A, Barnes R, Ferguson P, Pacilli M. Factors affecting mechanical complications of central venous access devices in children. Pediatr Surg Int. 2022; 38:1067-73.
Cesaro S, Corrò R, Pelosi A, Gamba P, Zadra N, Fusaro F, et al. A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases. Ann Hematol. 2004; 83:183-8.
Ammar S, Sellami S, Sellami I, Hamad AB, Hbaieb M, Jarraya A, et al. Risk factors of early mortality after neonatal surgery in Tunisia. J Pediatr Surg. 2020; 55:2233-7.
Ammar S, Sellami S, Sellami I, B. Hamad A, Jarraya A, Zouari M, et al. Management of esophageal atresia and early predictive factors of mortality and morbidity in a developing country. Dis Esophagus. 2019; 32:135.
Farou N, Lucas C, Olympia RP. School nurses on the front lines of healthcare: Children with medical devices—central venous access device malfunctions and infections. NASN School Nurse. 2021; 36:328-32.
Fritsch LM, Le M, Elrod J, Wössmann W, Vincent D, Reinshagen K, et al. Surgical experience affects the outcome of central venous access catheter implantation in children: A retrospective cohort study. J Pediatr Hematol Oncol. 2022; 8:10-97.
Moir D, Bodenham A. A narrative review of long-term central venous access devices for the intensivist. J Intensive Care Soc. 2018; 19:236-46.
Cesaro S, Cavaliere M, Pegoraro A, Gamba P, Zadra N, Tridello G. A comprehensive approach to the prevention of central venous catheter complications: results of 10-year prospective surveillance in pediatric hematology-oncology patients. Ann Hematol. 2016; 95:817-25.
Scott-Warren VL, Morley RB. Paediatric vascular access. BJA Educ. 2015; 15:199-206
Fratino G, Molinari AC, Parodi S, Longo S, Saracco P, Castagnola E, et al. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol. 2005; 16:648-54.
Simon A, Graf N, Furtwängler R. Results of a multicentre survey evaluating clinical practice of port and Broviac management in paediatric oncology. Klinische Pädiatrie. 2013; 225:145-51.
Naik VM, Mantha SSP, Rayani BK. Vascular access in children. Indian J Anaesth. 2019; 63:737-45.
Blotte C, Styers J, Zhu H, Channabasappa N, Piper HG. A comparison of Broviac® and peripherally inserted central catheters in children with intestinal failure. J Pediatr Surg. 2017; 52:768-71.
Acosta CM, Tusman G. Ultrasound-guided brachiocephalic vein access in neonates and pediatric patients. Rev Esp Anestesiol Reanim (Engl Ed). 2021; 68:584-91.
Reddy SM, Soccorso G, Lawrence L, Bennett J, Jester I, Pachl M, et al. Ultrasound-guided percutaneous insertion of Broviac lines in infants less than 5kg: Prospective study of 100 consecutive procedures. . J Pediatr Surg. 2022; S0022-3468(22)00039-2.
Cotogni P, Mussa B, Degiorgis C, De Francesco A, Pittiruti M. Comparative complication rates of 854 central venous access devices for home parenteral nutrition in cancer patients: a prospective study of over 169,000 catheter‐days. JPEN J Parenter Enteral Nutr. 2021; 45:768-76.
Merchaoui Z, Laudouar Q, Marais C, Morin L, Ghali N, Charbel R, et al. Ultrasound guided percutaneous catheterization of the brachiocephalic vein by small caliber catheter: An alternative to epicutaneo-caval catheter in newborn and premature infants. J Vasc Access. 2021: 11297298211034311.
Alshafei A, Tareen F, Maphango N, White D, O'Connor B, Sriparan T. Open tunneled central line insertion in children—External or internal jugular vein?. J Pediatr Surg. 2018; 53:2318-21.
Fitzgerald RK, Jennifer CY, Rajasekaran S, Curtis SE, Robertson DJ, Wincek JM, et al. Cost and safety of pediatric intensive care physician-placed broviac catheters. Pediatr Crit Care Med. 2014; 15:71-6.
How to Cite
Copyright (c) 2022 Manel Kammoun, Anouar Jarraya, Hend Ketata, Saloua Ammar, Mohamed Zouari, Chiraz Regaieg, Nadia Hentati, Mahdi Ben Dhaou, Riadh Mhiri
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.